Author
S. Tagami
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2020-2023 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 15 mutual co-author links5 papers
Recent·Most cited
Cell-free mutant analysis combined with structure prediction of a lasso peptide biosynthetic protein B2
A. Alfi, A. Popov, A. Kumar, K. Y. J. Zhang, S. Dubiley, K. Severinov, S. Tagami
The paper combines cell-free mutagenesis with AlphaFold2 structure prediction to validate the function of TfuB2, revealing a hydrophobic binding site for TfuB1.
bioRxiv · Apr 6, 2022Biochemistry
Seven amino acid types suffice to reconstruct the core fold of RNA polymerase
S. Yagi, A. K. Padhi, J. Vucinic, S. Barbe, T. Schiex, R. Nakagawa, D. Simoncini, K. Y. J. Zhang, S. Tagami
The paper reconstructs the DPBB fold using only seven amino acid types, suggesting it could have emerged with the early genetic code.
bioRxiv · Feb 22, 2021Biochemistry
Efficient Development of Platform Cell Lines Using CRISPR-Cas9 and Transcriptomics Analysis
A. T.-J. Kwon, K. Mohri, S. Takizawa, T. Arakawa, M. Takahashi, B. Kaczkowski, M. Furuno, H. Suzuki, S. Tagami, H. Mukai, E. Arner
The paper develops CRISPR-Cas9 mutants of U87MG cells to create platform cell lines for drug testing, finding that transcriptomic analysis helps identify clones with minimal phenotypic divergence from wild type.
bioRxiv · Sep 16, 2020 · PreprintBioengineering